COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study

DOI: 10.1186/s12959-018-0176-2

Keywords: Active cancer, Health-related quality of life, Low molecular weight heparin, Patient preference, Recurrent venous thromboembolism, Rivaroxaban, Vitamin K antagonist

Full-Text   Cite this paper   Add to My Lib

Abstract:

The online version of this article (10.1186/s12959-018-0176-2) contains supplementary material, which is available to authorized users

Full-Text